New device greatly increases esophageal dysplasia, Barrett's esophagus detection — 3 insights

A study published in Disease of the Esophagus examined the effectiveness of CDx Diagnostics WATS3D device in detecting esophageal dysplasia and Barrett's esophagus.

Researchers studied exam data for 12,899 patients. Endoscopists utilized WATS as an adjunct to targeted and random forceps biopsy. They alternated between WATS and FB samples.

Here's what you should know:

1. Forceps biopsy identified 88 cases of esophageal dysplasia and WATS identified an additional 213 cases missed by FB.

2. Adding WATS to FB increased detection by 242 percent.

3. The combination of random and targeted FB identified 1,684 Barrett's esophagus cases. WATS identified an additional 2,570 cases. Adding WATS to FB increased overall detection by 153 percent.

Lead study author Michael Smith, MD, said, "With the results of this and other published studies, the evidence is overwhelming that we should be using WATS3D along with forceps biopsies to evaluate all of our BE patients. We should not rely solely on techniques like forceps sampling, which clearly miss evidence of progression toward esophageal adenocarcinoma, an often fatal disease."

More articles on gastroenterology:
The story behind the Frazier, Atlanta Gastroenterology Associates deal — United Digestive CEO Mark Gilreath explains
Judge sides with independent physician organization in $58M class-action lawsuit — 4 insights
How to overcome the big challenges for orthopedic surgery centers in 2019 and key growth opportunities: Dr. Keith Berend

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers